Communications Strategist Cecilia Arradaza Joins BrightFocus Foundation Board of Directors

  • Press Release
Published on:

Cecilia Arradanza
BrightFocus Foundation, a Maryland-based nonprofit supporting innovative research worldwide on Alzheimer’s, macular degeneration, and glaucoma, today announced that communications strategist Cecilia Arradaza has joined the organization’s Board of Directors.

Currently the senior director of communications at the Biden Cancer Initiative, Arradaza has a long track record of success in strategic communications and marketing, particularly in health, science, and finance. 

“I’m privileged to join this remarkable effort to advance science and improve lives,” said Arradaza, who added a strong personal interest. “It was devastating for me to see Alzheimer’s rob my father of his sense of self.  Alzheimer’s and other neurodegenerative diseases upend families and communities every single day.”

Prior to her position at the Biden Cancer Initiative, Arradaza held leadership roles at global advisory firm Brunswick Group; the Milken Institute and its centers, FasterCures and the Center for Financial Markets; and public affairs firms Chandler Chicco Agency, Hyde Park Communications, and Powell Tate.

“The BrightFocus Board is honored to have Cecilia Arradaza join our efforts to cure diseases of mind and sight,” noted Board Chair Scott Rodgville, CPA. “Her strong instincts and experiences in strategic communications will help guide us in educating the public on the importance of science in ending these diseases.”

As the Baby Boom generation ages and Americans live longer, BrightFocus continues to expand its investment in groundbreaking science worldwide.  The foundation is currently managing a global portfolio of 175 research projects, an over $35 million investment supporting the untried, the unexpected, and the most promising paths to a cure.